EpiTherapeutics Overview

  • Founded
  • 2008
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 11
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $63.2M
Latest Deal Amount

EpiTherapeutics General Information

Description

Developer of small-molecule therapies for cancer treatment. The company has generated a library of selective small molecule inhibitors of epigenetic regulation of gene transcription, in particular histone demethylases. The company's lead pre-clinical compounds are being studied for the treatment of certain cancers.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Acquirer
Primary Office
  • Ole Maaløesvej 3
  • 2200 Copenhagen
  • Denmark
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

EpiTherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 06-May-2015 $63.2M 000.00 000.00 Completed Generating Revenue
4. Early Stage VC 26-Apr-2013 000.00 Completed Generating Revenue
3. Early Stage VC (Series A) 27-Feb-2013 00.000 000.00 Completed Generating Revenue
2. Seed Round 11-Feb-2010 $1.88M $4.84M Completed Startup
1. Seed Round 14-Oct-2009 $2.96M $2.96M Completed Startup
To view EpiTherapeutics’s complete valuation and funding history, request access »

EpiTherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of small-molecule therapies for cancer treatment. The company has generated a library of selective small molec
Drug Discovery
Copenhagen, Denmark
11 As of 2015
000.00
00.00 0000-00-00
000000&0 000.00

0000000

reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaeca
0000 000000000
Muttenz, Switzerland
00 As of 0000
000.00
000000 0

0000000

lore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqui
0000000000000
San Diego, CA
00 As of 0000
000
000000000 - 000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

EpiTherapeutics Competitors (23)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
TOLREMO therapeutics Venture Capital-Backed Muttenz, Switzerland 00 000.00 000000 0
0000000 0000000000 Formerly PE-Backed San Diego, CA 00 000 000000000 - 000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
0000000 0000000000 Formerly VC-backed Cambridge, United Kingdom 00 00000 000000000 00000
00000000 000000000 Venture Capital-Backed Uppsala, Sweden 00 0000000000
You’re viewing 5 of 23 competitors. Get the full list »

EpiTherapeutics Executive Team (8)

Name Title Board Seat Contact Info
Peter Staller Director, Oncology Research
Ivan Melezínek MD Chief Medical Officer
You’re viewing 2 of 8 executive team members. Get the full list »

EpiTherapeutics Board Members (9)

Name Representing Role Since
Ali Fattaey Ph.D Self Board Member 000 0000
Jasper Bos Ph.D M Ventures Board Member 000 0000
You’re viewing 2 of 9 board members. Get the full list »

EpiTherapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EpiTherapeutics Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Astellas Venture Management Corporate Venture Capital Minority 000 0000 000000 0
Life Science Investments Venture Capital Minority 000 0000 000000 0
Lundbeckfond Emerge Venture Capital Minority 000 0000 000000 0
Lundbeckfond Ventures Corporate Venture Capital Minority 000 0000 000000 0
M Ventures Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »